Your browser doesn't support javascript.
loading
Evaluation of the Safety, Tolerability, and Pharmacokinetics of GSK2269557 (Nemiralisib) Administered Via Dry Powder Inhaler to Healthy Japanese Subjects.
Ino, Hiroko; Wilson, Robert; Terao, Takumi; Ogura, Hirofumi; Igarashi, Harue; Cahn, Anthony; Numachi, Yotaro.
Afiliación
  • Ino H; Medicines Development (Clinical Pharmacology Office), Japan Development Division, GlaxoSmithKline K.K., Tokyo, Japan.
  • Wilson R; Clinical Pharmacology Modelling and Simulation, Medicine's Research Centre, GlaxoSmithKline, Stevenage, Hertfordshire, UK.
  • Terao T; Biomedical Data Sciences Department, Japan Development Division, GlaxoSmithKline K.K., Tokyo, Japan.
  • Ogura H; Medicines Development (Clinical Pharmacology Office), Japan Development Division, GlaxoSmithKline K.K., Tokyo, Japan.
  • Igarashi H; Pre-Clinical Development, Japan Development Division, GlaxoSmithKline K.K., Tokyo, Japan.
  • Cahn A; Pharma Research & Development, Respiratory TAU, GlaxoSmithKline, Stevenage, UK.
  • Numachi Y; Medicines Development, Japan Development Division, GlaxoSmithKline K.K., Tokyo, Japan.
Clin Pharmacol Drug Dev ; 8(1): 78-86, 2019 01.
Article en En | MEDLINE | ID: mdl-30303626
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Oxazoles / Piperazinas / Inhibidores de Proteínas Quinasas / Indazoles / Indoles Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Clin Pharmacol Drug Dev Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Oxazoles / Piperazinas / Inhibidores de Proteínas Quinasas / Indazoles / Indoles Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Clin Pharmacol Drug Dev Año: 2019 Tipo del documento: Article